Moonshot AI confidentially filed an application for a Hong Kong initial public offering on September 4, according to sources cited by Reuters. The sources said the Chinese AI company was targeting about $3 billion in proceeds, although the filing is not publicly available and the proposed offering remains subject to approvals and market conditions.
Reuters reports confidential Hong Kong IPO application
Reuters, citing unnamed sources, reported that Moonshot AI had confidentially applied for a Hong Kong IPO. The filing was not publicly available, meaning investors could not review a prospectus or assess prospective share-sale terms from a public filing.
Moonshot AI had not publicly confirmed IPO plans or the reported application. In a statement reported by the South China Morning Post on September 3, the company said it does not comment on market rumours or speculation and had no information to disclose at that time. The response preceded Reuters’ September 4 report by one day; Moonshot AI itself had therefore not confirmed the application’s existence, its terms or the eventual listing timetable.
Sources put Moonshot target proceeds near $3 billion
Reuters’ sources put Moonshot AI’s targeted IPO proceeds at approximately $3 billion, but the amount is not a final deal size.
Regulatory approvals and market conditions could affect an offering’s size and timing.
No public timetable was reported alongside the confidential application. No publicly available filing set out the planned number of shares, price range or other transaction terms.
Reported $50 billion valuation and IPO advisers
About $50 billion was the valuation Reuters reported for Moonshot AI’s ongoing funding round—not a confirmed valuation for a potential Hong Kong listing.
Sources cited by Reuters said the company was working with Goldman Sachs, China International Capital Corp. (CICC) and Deutsche Bank on the potential IPO. The reporting did not publicly confirm the banks’ roles or the prospective offering terms.
Separately, the reported IPO target was $3 billion. That figure remained contingent on regulatory approvals and market conditions, according to Reuters’ sources.
Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.